Simurx, Inc is a pre-clinical stage biopharmaceutical company based in Pasadena, California. They specialize in developing innovative T-cell technologies and gene engineering tools to advance cellular immunotherapies for patients with high unmet medical needs.
With a team of experts in genomic technologies, immunology, and disease microenvironment, Simurx combines their world-class expertise to create novel synthetic biology approaches to cellular immunotherapy, aiming to enhance patient care and address critical medical challenges.
Generated from the website